February | 2017 | Neupsy Key

Oral dopamine agonists in the management of Parkinson’s disease

Feb 16, 2017 by admin in NEUROLOGY Comments Off

html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 5 Oral dopamine agonists in the management of Parkinson’s disease Javier Pagonabarraga, Juan Marín-Lahoz and Jaime Kulisevsky Introduction and history In 1960 and 1967, Hornykiewicz…

Anticholinergic agents in the management of Parkinson’s disease

Feb 16, 2017 by admin in NEUROLOGY Comments Off

Figure 2.1 Prescription of anticholinergic treatment used by Professor Charcot, dated 1887 from the College of Physicians of Philadelphia Library. The cholinergic system and Parkinson’s disease Some authors have postulated…

Monoamine oxidase inhibitors in the management of Parkinson’s disease

Feb 16, 2017 by admin in NEUROLOGY Comments Off

html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 4 Monoamine oxidase inhibitors in the management of Parkinson’s disease Sven-Eric Pålhagen Introduction Monoamine oxidase B (MAO-B) inhibitors have again become relevant as a good…

Newer Entries »

Neupsy Key

Fastest Neupsy Insight Engine

Oral dopamine agonists in the management of Parkinson’s disease

Anticholinergic agents in the management of Parkinson’s disease

Monoamine oxidase inhibitors in the management of Parkinson’s disease

Preparation of the Stereotaxic Surgical Procedure

Elements of Descriptive Neuroanatomy

Stereotaxic Approach of a Target Structure

Realization of the Stereotaxic Surgery

Elements of Functional Neuroanatomy: The Major Neurotransmitter Systems

Post-mortem Examination of Animals

Regulatory and Ethical Considerations

Recent Posts

Recent Comments

Archives

Categories

Meta